Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study.

Doyle M, Weinberg N, Pohost GM, Merz CN, Shaw LJ, Sopko G, Fuisz A, Rogers WJ, Walsh EG, Johnson BD, Sharaf BL, Pepine CJ, Mankad S, Reis SE, Rayarao G, Vido DA, Bittner V, Tauxe L, Olson MB, Kelsey SF, Biederman RW.

Cardiovasc Diagn Ther. 2013 Jun;3(2):64-72.

2.

Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.

Doyle M, Weinberg N, Pohost GM, Bairey Merz CN, Shaw LJ, Sopko G, Fuisz A, Rogers WJ, Walsh EG, Johnson BD, Sharaf BL, Pepine CJ, Mankad S, Reis SE, Vido DA, Rayarao G, Bittner V, Tauxe L, Olson MB, Kelsey SF, Biederman RW.

JACC Cardiovasc Imaging. 2010 Oct;3(10):1030-6. doi: 10.1016/j.jcmg.2010.07.008.

3.

Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE).

Doyle M, Pohost GM, Bairey Merz CN, Shaw LJ, Sopko G, Rogers WJ, Sharaf BL, Pepine CJ, Thompson DV, Rayarao G, Tauxe L, Kelsey SF, Biederman RW.

Cardiovasc Diagn Ther. 2016 Oct;6(5):424-431.

4.

Improved diagnosis and prognosis using Decisions Informed by Combining Entities (DICE): results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).

Doyle M, Pohost GM, Merz CN, Shaw LJ, Sopko G, Rogers WJ, Sharaf BL, Pepine CJ, Vido-Thompson DA, Rayarao G, Tauxe L, Kelsey SF, Mc Nair D, Biederman RW.

Cardiovasc Diagn Ther. 2013 Dec;3(4):216-27. doi: 10.3978/j.issn.2223-3652.2013.10.07.

5.

Poststress left ventricular ejection fraction is an independent predictor of major cardiac events in patients with coronary artery disease and impaired left ventricular function.

De Winter O, Van De Veire N, De Bondt P, Van De Wiele C, De Buyzere M, De Backer G, Gillebert TC, Dierckx RA, De Sutter J.

Q J Nucl Med Mol Imaging. 2008 Sep;52(3):296-304. Epub 2007 Jan 15.

7.

Prognostic value of combined magnetic resonance myocardial perfusion imaging and late gadolinium enhancement.

Krittayaphong R, Chaithiraphan V, Maneesai A, Udompanturak S.

Int J Cardiovasc Imaging. 2011 Jun;27(5):705-14. doi: 10.1007/s10554-011-9863-9. Epub 2011 Apr 10.

PMID:
21479846
8.

Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2010;10(15):1-45. Epub 2010 Jul 1.

9.

Prediction of new-onset refractory congestive heart failure using gated myocardial perfusion SPECT imaging in patients with known or suspected coronary artery disease subanalysis of the J-ACCESS database.

Nakata T, Hashimoto A, Wakabayashi T, Kusuoka H, Nishimura T.

JACC Cardiovasc Imaging. 2009 Dec;2(12):1393-400. doi: 10.1016/j.jcmg.2009.09.010.

10.

Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study.

Nishimura T, Nakajima K, Kusuoka H, Yamashina A, Nishimura S.

Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):319-28. Epub 2007 Oct 10. Erratum in: Eur J Nucl Med Mol Imaging. 2008 Sep;35(9):1745.

PMID:
17926033
11.

Prognostic value of poststress left ventricular volume and ejection fraction by gated myocardial perfusion SPECT in women and men: gender-related differences in normal limits and outcomes.

Sharir T, Kang X, Germano G, Bax JJ, Shaw LJ, Gransar H, Cohen I, Hayes SW, Friedman JD, Berman DS.

J Nucl Cardiol. 2006 Jul;13(4):495-506.

PMID:
16919573
12.

Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study.

Arant CB, Wessel TR, Olson MB, Bairey Merz CN, Sopko G, Rogers WJ, Sharaf BL, Reis SE, Smith KM, Johnson BD, Handberg E, Mankad S, Pepine CJ; National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study..

J Am Coll Cardiol. 2004 Jun 2;43(11):2009-14.

13.

Myocardial perfusion imaging is a strong predictor of death in women.

Cerci MS, Cerci JJ, Cerci RJ, Pereira Neto CC, Trindade E, Delbeke D, da Cunha CL, Vitola JV.

JACC Cardiovasc Imaging. 2011 Aug;4(8):880-8. doi: 10.1016/j.jcmg.2011.06.009.

14.

Hostility scores are associated with increased risk of cardiovascular events in women undergoing coronary angiography: a report from the NHLBI-Sponsored WISE Study.

Olson MB, Krantz DS, Kelsey SF, Pepine CJ, Sopko G, Handberg E, Rogers WJ, Gierach GL, McClure CK, Merz CN; WISE Study Group..

Psychosom Med. 2005 Jul-Aug;67(4):546-52.

PMID:
16046366
15.

Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.

Arant CB, Wessel TR, Ridker PM, Olson MB, Reis SE, Delia Johnson B, Sharaf BL, Pauly DF, Handberg E, Zineh I, Sopko G, Kelsey SF, Noel Bairey Merz C, Pepine CJ.

Clin Cardiol. 2009 May;32(5):244-50. doi: 10.1002/clc.20454.

16.

Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2010;10(16):1-80. Epub 2010 Jul 1.

17.

Prevalence and predictors of ischemia and outcomes in outpatients with diabetes mellitus referred for single-photon emission computed tomography myocardial perfusion imaging.

Bourque JM, Patel CA, Ali MM, Perez M, Watson DD, Beller GA.

Circ Cardiovasc Imaging. 2013 May 1;6(3):466-77. doi: 10.1161/CIRCIMAGING.112.000259. Epub 2013 Apr 1.

18.

Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.

Wei J, Mehta PK, Johnson BD, Samuels B, Kar S, Anderson RD, Azarbal B, Petersen J, Sharaf B, Handberg E, Shufelt C, Kothawade K, Sopko G, Lerman A, Shaw L, Kelsey SF, Pepine CJ, Merz CN.

JACC Cardiovasc Interv. 2012 Jun;5(6):646-53. doi: 10.1016/j.jcin.2012.01.023.

19.

Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2005;5(16):1-167. Epub 2005 Oct 1.

20.

Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.

Pepine CJ, Anderson RD, Sharaf BL, Reis SE, Smith KM, Handberg EM, Johnson BD, Sopko G, Bairey Merz CN.

J Am Coll Cardiol. 2010 Jun 22;55(25):2825-32. doi: 10.1016/j.jacc.2010.01.054.

Supplemental Content

Support Center